 | • レポートコード：QYR9N7968 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、rhEPOのグローバル市場について調査・分析したレポートで、種類別（ESRD、がん、HIV、創傷と神経疾患）、用途別（病院、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・rhEPOの世界市場規模 ・主要企業別市場シェア ・rhEPOの世界市場規模：種類別（ESRD、がん、HIV、創傷と神経疾患） ・rhEPOの世界市場規模：用途別（病院、小売薬局） ・rhEPOのアメリカ市場規模（種類別、用途別） ・rhEPOのヨーロッパ市場規模（種類別、用途別） ・rhEPOの中国市場規模（種類別、用途別） ・rhEPOの日本市場規模（種類別、用途別） ・rhEPOの東南アジア市場規模（種類別、用途別） ・rhEPOのインド市場規模（種類別、用途別） ・rhEPOの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・rhEPOの世界市場予測（2019年-2025年） ・rhEPOの地域別市場予測（2019年-2025年） ... |
The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.In 2018, the global rhEPO market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global rhEPO status, future forecast, growth opportunity, key market and key players. The study objectives are to present the rhEPO development in United States, Europe and China.
The key players covered in this study
3SBio
Shanghai Chemo
Chengdu Diao
NCPC Genetech
Kyowa Hakko Kirin
Shandong Kexing
Ahua Pharmaceutical
Biosidus
Dragon Pharma
Market segment by Type, the product can be split into
ESRD
Cancer
HIV
Wounds and neural disease
Market segment by Application, split into
Hospitals
Retail Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global rhEPO status, future forecast, growth opportunity, key market and key players.
To present the rhEPO development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of rhEPO are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global rhEPO Market Size Growth Rate by Type (2014-2025)
1.4.2 ESRD
1.4.3 Cancer
1.4.4 HIV
1.4.5 Wounds and neural disease
1.5 Market by Application
1.5.1 Global rhEPO Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 rhEPO Market Size
2.2 rhEPO Growth Trends by Regions
2.2.1 rhEPO Market Size by Regions (2014-2025)
2.2.2 rhEPO Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 rhEPO Market Size by Manufacturers
3.1.1 Global rhEPO Revenue by Manufacturers (2014-2019)
3.1.2 Global rhEPO Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global rhEPO Market Concentration Ratio (CR5 and HHI)
3.2 rhEPO Key Players Head office and Area Served
3.3 Key Players rhEPO Product/Solution/Service
3.4 Date of Enter into rhEPO Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global rhEPO Market Size by Type (2014-2019)
4.2 Global rhEPO Market Size by Application (2014-2019)
5 United States
5.1 United States rhEPO Market Size (2014-2019)
5.2 rhEPO Key Players in United States
5.3 United States rhEPO Market Size by Type
5.4 United States rhEPO Market Size by Application
6 Europe
6.1 Europe rhEPO Market Size (2014-2019)
6.2 rhEPO Key Players in Europe
6.3 Europe rhEPO Market Size by Type
6.4 Europe rhEPO Market Size by Application
7 China
7.1 China rhEPO Market Size (2014-2019)
7.2 rhEPO Key Players in China
7.3 China rhEPO Market Size by Type
7.4 China rhEPO Market Size by Application
8 Japan
8.1 Japan rhEPO Market Size (2014-2019)
8.2 rhEPO Key Players in Japan
8.3 Japan rhEPO Market Size by Type
8.4 Japan rhEPO Market Size by Application
9 Southeast Asia
9.1 Southeast Asia rhEPO Market Size (2014-2019)
9.2 rhEPO Key Players in Southeast Asia
9.3 Southeast Asia rhEPO Market Size by Type
9.4 Southeast Asia rhEPO Market Size by Application
10 India
10.1 India rhEPO Market Size (2014-2019)
10.2 rhEPO Key Players in India
10.3 India rhEPO Market Size by Type
10.4 India rhEPO Market Size by Application
11 Central & South America
11.1 Central & South America rhEPO Market Size (2014-2019)
11.2 rhEPO Key Players in Central & South America
11.3 Central & South America rhEPO Market Size by Type
11.4 Central & South America rhEPO Market Size by Application
12 International Players Profiles
12.1 3SBio
12.1.1 3SBio Company Details
12.1.2 Company Description and Business Overview
12.1.3 rhEPO Introduction
12.1.4 3SBio Revenue in rhEPO Business (2014-2019)
12.1.5 3SBio Recent Development
12.2 Shanghai Chemo
12.2.1 Shanghai Chemo Company Details
12.2.2 Company Description and Business Overview
12.2.3 rhEPO Introduction
12.2.4 Shanghai Chemo Revenue in rhEPO Business (2014-2019)
12.2.5 Shanghai Chemo Recent Development
12.3 Chengdu Diao
12.3.1 Chengdu Diao Company Details
12.3.2 Company Description and Business Overview
12.3.3 rhEPO Introduction
12.3.4 Chengdu Diao Revenue in rhEPO Business (2014-2019)
12.3.5 Chengdu Diao Recent Development
12.4 NCPC Genetech
12.4.1 NCPC Genetech Company Details
12.4.2 Company Description and Business Overview
12.4.3 rhEPO Introduction
12.4.4 NCPC Genetech Revenue in rhEPO Business (2014-2019)
12.4.5 NCPC Genetech Recent Development
12.5 Kyowa Hakko Kirin
12.5.1 Kyowa Hakko Kirin Company Details
12.5.2 Company Description and Business Overview
12.5.3 rhEPO Introduction
12.5.4 Kyowa Hakko Kirin Revenue in rhEPO Business (2014-2019)
12.5.5 Kyowa Hakko Kirin Recent Development
12.6 Shandong Kexing
12.6.1 Shandong Kexing Company Details
12.6.2 Company Description and Business Overview
12.6.3 rhEPO Introduction
12.6.4 Shandong Kexing Revenue in rhEPO Business (2014-2019)
12.6.5 Shandong Kexing Recent Development
12.7 Ahua Pharmaceutical
12.7.1 Ahua Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 rhEPO Introduction
12.7.4 Ahua Pharmaceutical Revenue in rhEPO Business (2014-2019)
12.7.5 Ahua Pharmaceutical Recent Development
12.8 Biosidus
12.8.1 Biosidus Company Details
12.8.2 Company Description and Business Overview
12.8.3 rhEPO Introduction
12.8.4 Biosidus Revenue in rhEPO Business (2014-2019)
12.8.5 Biosidus Recent Development
12.9 Dragon Pharma
12.9.1 Dragon Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 rhEPO Introduction
12.9.4 Dragon Pharma Revenue in rhEPO Business (2014-2019)
12.9.5 Dragon Pharma Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table rhEPO Key Market Segments
Table Key Players rhEPO Covered
Table Global rhEPO Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global rhEPO Market Size Market Share by Type 2014-2025
Figure ESRD Figures
Table Key Players of ESRD
Figure Cancer Figures
Table Key Players of Cancer
Figure HIV Figures
Table Key Players of HIV
Figure Wounds and neural disease Figures
Table Key Players of Wounds and neural disease
Table Global rhEPO Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Retail Pharmacies Case Studies
Figure rhEPO Report Years Considered
Table Global rhEPO Market Size 2014-2025 (Million US$)
Figure Global rhEPO Market Size and Growth Rate 2014-2025 (Million US$)
Table Global rhEPO Market Size by Regions 2014-2025 (Million US$)
Table Global rhEPO Market Size by Regions 2014-2019 (Million US$)
Table Global rhEPO Market Share by Regions 2014-2019
Figure Global rhEPO Market Share by Regions 2014-2019
Figure Global rhEPO Market Share by Regions 2019
Table Market Top Trends
Table Global rhEPO Revenue by Manufacturers (2014-2019) (Million US$)
Table Global rhEPO Market Share by Manufacturers (2014-2019)
Figure Global rhEPO Market Share by Manufacturers in 2018
Table Global rhEPO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players rhEPO Product/Solution/Service
Table Date of Enter into rhEPO Market
Table Mergers & Acquisitions, Expansion Plans
Table Global rhEPO Market Size by Type (2014-2019) (Million US$)
Table Global rhEPO Market Size Share by Type (2014-2019)
Figure Global rhEPO Market Size Market Share by Type (2014-2019)
Table Global rhEPO Market Size by Application (2014-2019) (Million US$)
Table Global rhEPO Market Size Share by Application (2014-2019)
Figure Global rhEPO Market Size Market Share by Application (2014-2019)
Figure Global rhEPO Revenue Market Share by Application in 2018
Figure United States rhEPO Market Size 2014-2019 (Million US$)
Table United States Key Players rhEPO Revenue (2018-2019) (Million US$)
Table United States Key Players rhEPO Market Share (2018-2019)
Table United States rhEPO Market Size by Type (2014-2019) (Million US$)
Table United States rhEPO Market Share by Type (2014-2019)
Table United States rhEPO Market Size by Application (2014-2019) (Million US$)
Table United States rhEPO Market Share by Application (2014-2019)
Figure Europe rhEPO Market Size 2014-2019 (Million US$)
Table Europe Key Players rhEPO Revenue (2018-2019) (Million US$)
Table Europe Key Players rhEPO Market Share (2018-2019)
Table Europe rhEPO Market Size by Type (2014-2019) (Million US$)
Table Europe rhEPO Market Share by Type (2014-2019)
Table Europe rhEPO Market Size by Application (2014-2019) (Million US$)
Table Europe rhEPO Market Share by Application (2014-2019)
Figure China rhEPO Market Size 2014-2019 (Million US$)
Table China Key Players rhEPO Revenue (2018-2019) (Million US$)
Table China Key Players rhEPO Market Share (2018-2019)
Table China rhEPO Market Size by Type (2014-20189) (Million US$)
Table China rhEPO Market Share by Type (2014-2019)
Table China rhEPO Market Size by Application (2014-2019) (Million US$)
Table China rhEPO Market Share by Application (2014-2019)
Figure Japan rhEPO Market Size 2014-2019 (Million US$)
Table Japan Key Players rhEPO Revenue (2018-2019) (Million US$)
Table Japan Key Players rhEPO Market Share (2018-2019)
Table Japan rhEPO Market Size by Type (2014-2019) (Million US$)
Table Japan rhEPO Market Share by Type (2014-2019)
Table Japan rhEPO Market Size by Application (2014-2019) (Million US$)
Table Japan rhEPO Market Share by Application (2014-2019)
Figure Southeast Asia rhEPO Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players rhEPO Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players rhEPO Market Share (2018-2019)
Table Southeast Asia rhEPO Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia rhEPO Market Share by Type (2014-2019)
Table Southeast Asia rhEPO Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia rhEPO Market Share by Application (2014-2019)
Figure India rhEPO Market Size 2014-2019 (Million US$)
Table India Key Players rhEPO Revenue (2018-2019) (Million US$)
Table India Key Players rhEPO Market Share (2018-2019)
Table India rhEPO Market Size by Type (2014-2019) (Million US$)
Table India rhEPO Market Share by Type (2014-2019)
Table India rhEPO Market Size by Application (2014-2019) (Million US$)
Table India rhEPO Market Share by Application (2014-2019)
Figure Central & South America rhEPO Market Size 2014-2019 (Million US$)
Table Central & South America Key Players rhEPO Revenue (2018-2019) (Million US$)
Table Central & South America Key Players rhEPO Market Share (2018-2019)
Table Central & South America rhEPO Market Size by Type (2014-2019) (Million US$)
Table Central & South America rhEPO Market Share by Type (2014-2019)
Table Central & South America rhEPO Market Size by Application (2014-2019) (Million US$)
Table Central & South America rhEPO Market Share by Application (2014-2019)
Table 3SBio Company Details
Table 3SBio Revenue in rhEPO Business (2014-2019) (Million US$)
Figure 3SBio Revenue Growth Rate in rhEPO Business (2014-2019)
Table 3SBio Recent Development
Table Shanghai Chemo Company Details
Table Shanghai Chemo Revenue in rhEPO Business (2014-2019)(Million US$)
Figure Shanghai Chemo Revenue Growth Rate in rhEPO Business (2014-2019)
Table Shanghai Chemo Recent Development
Table Chengdu Diao Company Details
Table Chengdu Diao Revenue in rhEPO Business (2014-2019)(Million US$)
Figure Chengdu Diao Revenue Growth Rate in rhEPO Business (2014-2019)
Table Chengdu Diao Recent Development
Table NCPC Genetech Company Details
Table NCPC Genetech Revenue in rhEPO Business (2014-2019)(Million US$)
Figure NCPC Genetech Revenue Growth Rate in rhEPO Business (2014-2019)
Table NCPC Genetech Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Revenue in rhEPO Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Revenue Growth Rate in rhEPO Business (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table Shandong Kexing Company Details
Table Shandong Kexing Revenue in rhEPO Business (2014-2019)(Million US$)
Figure Shandong Kexing Revenue Growth Rate in rhEPO Business (2014-2019)
Table Shandong Kexing Recent Development
Table Ahua Pharmaceutical Company Details
Table Ahua Pharmaceutical Revenue in rhEPO Business (2014-2019)(Million US$)
Figure Ahua Pharmaceutical Revenue Growth Rate in rhEPO Business (2014-2019)
Table Ahua Pharmaceutical Recent Development
Table Biosidus Company Details
Table Biosidus Revenue in rhEPO Business (2014-2019)(Million US$)
Figure Biosidus Revenue Growth Rate in rhEPO Business (2014-2019)
Table Biosidus Recent Development
Table Dragon Pharma Company Details
Table Dragon Pharma Revenue in rhEPO Business (2014-2019)(Million US$)
Figure Dragon Pharma Revenue Growth Rate in rhEPO Business (2014-2019)
Table Dragon Pharma Recent Development
Table Global rhEPO Market Size by Regions (Million US$) 2019-2025
Figure Global rhEPO Market Size Share by Regions (2019-2025)
Figure Global rhEPO Market Size Share by Regions in 2025
Figure United States rhEPO Market Size Forecast (2019-2025)(Million USD)
Figure Europe rhEPO Market Size Forecast (2019-2025)(Million USD)
Figure China rhEPO Market Size Forecast (2019-2025)(Million USD)
Figure Japan rhEPO Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia rhEPO Market Size Forecast (2019-2025)(Million USD)
Figure India rhEPO Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America rhEPO Market Size Forecast (2019-2025)(Million USD)
Table Global rhEPO Market Size by Product (2019-2025) (Million US$)
Figure Global rhEPO Market Size by Product (2019-2025)
Figure Global rhEPO Market Size by Product in 2025
Table Global rhEPO Market Size by Application (2019-2025) (Million US$)
Figure Global rhEPO Market Size by Application (2019-2025)
Figure Global rhEPO Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のクッシング病治療市場：市場規模・現状・予測 Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…- 世界のまれな神経疾患治療市場：市場規模・現状・予測 In 2018, the global Rare Neurological Disease Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Rare Neurological Disease Treatment status, future forecast, growth opportunity, key mark…
- 世界のまれな病気の治療市場：市場規模・現状・予測 A rare disease is any disease that affects a small percentage of the population.Most rare diseases are genetic and thus are present throughout the person's entire life, even if symptoms do not immediately appear. In 2018, the global Rare Disease Treatment market size was xx million US$ and it is exp…
- 世界のペプチドベースのがん治療薬市場：市場規模・現状・予測 Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.In 2018, the global Peptide Based Cancer Therapeutics market size was…
- 世界のまれな内分泌疾患の治療市場：市場規模・現状・予測 The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive.The rare endocrine d…